Study in Subjects With Small Primary Choroidal Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

January 26, 2021

Study Completion Date

January 26, 2021

Conditions
Uveal MelanomaOcular MelanomaChoroidal Melanoma
Interventions
DRUG

Light-activated AU-011

Study treatment

DEVICE

Laser Activation

Study treatment

Trial Locations (13)

10027

Columbia University Medical Center, New York

19107

Wills Eye Hospital, Philadelphia

29605

Retina Consultants of Carolina, PA, Greenville

48073

Associated Retinal Consultants, PC, Royal Oak

48105

W. K. Kellogg Eye Center, University of Michigan, Ann Arbor

55404

Retina Center, Minneapolis

77030

Retina Consultants of Houston, Houston

80210

Colorado Retina Associates, Denver

85710

Retina Associates SW, P.C., Tucson

90095

UCLA Jules Stein Eye Institute, Los Angeles

94303

Byers Eye Institute at Stanford University, Palo Alto

95819

Retina Consultants of Sacramento, Sacramento

02114

Massachusetts Eye and Ear Infirmary, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aura Biosciences

INDUSTRY